WHO members' pandemic accord talks to spill into 2025

The key faultline in the negotiations lies between Western nations with major pharmaceutical industry sectors, and poorer countries who do not want to be sidelined when the next pandemic strikes.

The emergence of a new strain of mpox, the deadly Marburg virus outbreak in Rwanda and the spread of H5N1 bird flu in recent months have given the talks process a timely jolt.

The negotiations, which kicked off in February 2022, are being held at the World Health Organization's headquarters in Geneva.

The WHO's 194 member states "think they still have work to do", talks co-chair Anne-Claire Amprou told a press conference.

"Today member states agreed we need to conclude the agreement as soon as possible, and continue negotiations into 2025, with the goal of concluding the agreement by the next World Health Assembly scheduled in May.

"We are moving in the right direction," she insisted.

In December 2021, fearing a repeat of the devastation wrought by Covid-19 -- which killed millions of people, crippled health systems and crashed economies -- countries decided to draft a new accord on pandemic prevention, preparedness and response.

While much of the draft text has been agreed, disputes remain over some key provisions, notably over sharing access to pathogens with pandemic potential -- and then equitably sharing the benefits derived from them, such as vaccines, tests and treatments.

Talks are also stuck on surveillance and prevention, as well as technology transfer to poorer states.

'Still a chasm'

In June at the annual World Health Assembly -- the WHO's top decision-making body -- countries gave themselves until the next assembly in May 2025 to conclude and adopt the agreement -- and to get it done by the end of the year if possible.

To finish this year, countries would have had to call a special session of the assembly in December -- with Monday the last possible day to do so.

However, negotiators accepted they were still far from ready.

Countries will have a further week of talks next month and decide on December 6 whether they think an agreement can be sealed before May.

On the horizon, the return to the US presidency in January of Donald Trump -- no friend of the WHO -- also risks shaking up the process.

The two-week, 12th round of negotiations began on November 4, but little progress has been achieved so far on bridging the remaining gaps.

"In terms of the content, there's still a chasm. It's important to get the content right," Thiru Balasubramaniam, the Knowledge Ecology International NGO's Geneva representative, told AFP.

He said finding some give-and-take on ramping up surveillance for emerging pathogen threats, and equally on sharing pathogens and pandemic-fighting products, could break the logjam.

"If member states can thread the needle on those two difficult pieces of the puzzle, then the rest may follow," he said.

- 'Biggest fear' -

Talks co-chair Precious Matsoso said that all countries want to be better prepared and prevent the next disaster from happening.

"We are actually closer on some issues than we think... a clear opportunity exists for a middle ground," she said.

"Our biggest fear though is that when the next pandemic happens, it will be more severe than what we experienced with Covid-19."

K.M. Gopakumar, senior researcher with the Third World Network, said countries were discussing the conditions under which vaccines, tests and treatments would be shared for distribution among poorer countries, and what percentage of production.`

"Developed countries are saying they will give only in the case of a pandemic. But not for, say, a public health emergency of international concern, or even regular outbreak of say Ebola," he told AFP.

"As per this approach, they give only when it becomes big. That is exactly what happened with mpox. Only when there was a public health emergency was there a donation of vaccines. That is too late."